SpyrosAKalamsMD
Infectious Disease • Nashville, TNProfessor, Medicine, Vanderbilt University School of Medicine
Dr. Kalams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1161 21st Ave South
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605- Is this information wrong?
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1990 - 1994
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
Uconn School Of MedicineClass of 1987
Certifications & Licensure
TN State Medical License 2002 - 2025
MA State Medical License 1989 - 2004- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
- Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP Start of enrollment: 2004 Apr 01
- Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults
- Join now to see all
Publications & Presentations
PubMed
- Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients.Justin Z Amarin, Daniel E Dulek, Joshua Simmons, Haya Hayek, James D Chappell, Cindy Hager Nochowicz, Carrie L Kitko, Jennifer E Schuster, Flor M Muñoz, Claire E Bocch...> ;Blood Advances. 2024 Apr 23
- Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson Syndrome and Toxic epidermal necrolysis.Andrew Gibson, Ramesh Ram, Rama Gangula, Yueran Li, Eric Mukherjee, Amy M Palubinsky, Chelsea N Campbell, Michael Thorne, Katherine C Konvinse, Phuti Choshi, Pooja Des...> ;Biorxiv. 2024 Feb 18
- Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.Miner, M., deCamp, A., Grunenberg, N., De Rosa, S., Fiore-Gartland, A., Bar, K., Spearman, P., Allen, M., Yu, P., Manso, B., Frahm, N., Kalams, S., Baden, L., Keefer, ...> ;Ebiomedicine. 2024 Feb 1
- Join now to see all
Press Mentions
Researchers Use Fight Against COVID to Help with Development of HIV VaccineMarch 1st, 2022- More Unvaccinated People Still Need First COVID Vaccine, TN Doctors SayOctober 12th, 2021
- Vanderbilt to Give Booster Shots to Moderna Trial ParticipantsSeptember 20th, 2021
- Join now to see all
Hospital Affiliations
Vanderbilt University Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
